Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biologics vs Non-biologics Effects on Vascular Function in Psoriasis
NCT02144857Phase 4Unknown
- Sponsor
- National and Kapodistrian University of Athens
- Start
- May 2014
- Primary completion
- Sep 2023
- Modality
- Small Molecules, Peptides, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept, ustekinumab, secukinumab, apremilast, cyclosporine in psoriasis, sponsored by National and Kapodistrian University of Athens. Status: unknown.
02
Drugs
etanerceptustekinumabsecukinumabapremilastcyclosporine
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02144857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144857.